Fineotex Chemical Limited — Q4 FY25 earnings call

Call held 21 May 2025

Management summary

Fineotex Chemical Limited reported a flattish FY25 total income of Rs. 558 crores, with EBITDA margins softening to 23.85% due to strategic investments. While the FMCG segment faced temporary volume softness, new business lines like water treatment and oil & gas showed strong growth. The company is progressing with its greenfield expansion, set to add 15,000 MT capacity by Q2 FY26, and launched an innovative mosquito control solution. Management remains confident in future growth, leveraging new products and market diversification.

Highlights

  • New business lines (water treatment, oil & gas) delivered strong performance with a substantial increase in both volumes and value contributions.

  • Greenfield expansion is progressing well and aims to commence operation by Q2 FY26, adding 15,000 metric tonnes of capacity.

  • Launched AquaStrike Premium, a biotechnology-based mosquito control solution, which achieved a 100% mortality rate in 2-3 hours.

  • Added 25 new customers during Q4 and developed 30 new products during the quarter.

  • Gross profit margins remained stable at 38.57% for FY25.

Concerns

  • Total income for FY25 remained flattish at Rs. 558 crores year-on-year.

  • EBITDA margin softened by 222 basis points to 23.85% for FY25 due to CAPEX and brand building initiatives.

  • PAT for FY25 decreased to Rs. 109 crores from Rs. 121 crores in the previous corresponding year, a decline of 9.92% YoY.

  • The FMCG, cleaning, and hygiene segment witnessed a temporary softness in volumes, with an 18% volume drop in the detergent/FMCG sub-segment.

  • Certain deliveries were postponed during Q4 FY25 due to geopolitical tensions and trade disruptions, though expected to be fulfilled in the current financial year.

Key financials

  1. Total Income ₹558 Cr 0%YoY
  2. Gross Profit ₹205 Cr
  3. Gross Margin 38.6%
  4. EBITDA ₹127 Cr
  5. EBITDA Margin 23.9%
  6. PAT ₹109 Cr -9.9%YoY
  7. PAT Margin 20.5%
  8. Cash Balance ₹352 Cr
  9. ROCE 23.6%
  10. ROE 18.3%
  11. Operating Cash Flows ₹69.33 Cr
  12. CFO to EBITDA Ratio 54.5%
  13. Export Share 22%

What they filed

Q1 FY27: revenue up 175.2%, net profit up 92.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue146 126 120 137 138 −5%184 +46%314 +162%377 +175%
EBITDA36 34 21 25 31 −14%35 +3%44 +110%59 +136%
Net profit32 28 20 25 26 −19%30 +7%44 +120%48 +92%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

  • Textile Specialties
    73% Revenue Share15% Volume Growth10% Revenue Growth
  • Health & Hygiene / Cleaning (Detergent/FMCG sub-segment)
    -18% Volume Growth
  • Water Treatment & Oil & Gas
    strong qualitative Performancesubstantial increase qualitative Volume & Value Contribution

Capital allocation

high confidence
  • Capex Capex disclosed internal accruals and generating good cash
    • Greenfield expansion for new plant
    • New corporate office in Andheri
    • Enhanced production capabilities, strengthening market presence for new business segments
    We are undertaking focused capital expenditure and brand building initiatives. These investments are aimed at enhanced production capabilities, strengthening our market presence... We have enough of internal accruals and also generating good cash, so I do not think we have to worry on the cost of the expansion on that line for production capacities in future.
  • Liquidity Cash ₹352 Cr Cash balance is after CAPEX deployment in new facility and corporate office. Company has enough internal accruals and cash generation for future expansion.
    The cash balance and equivalent cash equivalents for the year is reported at Rs. 352 crores. This is after the cash deployment, CAPEX deployment in the new facility and the new corporate office located in Andheri, and the new plant which is upcoming for which already deployment has been taken... we have enough of internal accruals and also generating good cash, so I do not think we have to worry on the cost of the expansion on that line for production capacities in future.

Guidance & targets

Capacity

  • Greenfield expansion commissioning Capacity · Q2 FY26 · High confidence Commence operation by Q2 Financial Year 2026
    We are happy to report that it is progressing well and we aim to commence operation by Q2 Financial Year 2026.

    — Arindam Choudhuri

  • Total installed capacity Capacity · post Q2 FY26 · High confidence 1,20,000 metric tonne per annum
    This new facility will add 15,000 metric tonnes per annum of capacity taking our total installed capacity to 1,20,000 metric tonne per annum.

    — Arindam Choudhuri

Profitability

  • EBITDA margin Profitability · FY26 · High confidence around 24%
    However, as already mentioned, our EBITDA margin for the entire year is 24% as such. So going forward, we are quite confident with the new initiatives and the attention and the brand-building exercise which the Company has done in the new product segment. We are looking for strong concrete growth going forward, and we are quite confident that we will be having similar kind of performances as we have done in the last four or five years in the EBITDA percentages.

    — Sanjay Tibrewala

Segment Growth

  • Textile segment revival Segment Growth · from June onward · Medium confidence great revival
    in textiles we are hoping a great revival as far as the Indian markets are concerned especially from the coming months, from June onward.

    — Sanjay Tibrewala

Segment Outlook

  • Detergent market normalization Segment Outlook · coming months · Medium confidence normalized
    Detergent market are going to get normalized because the prices of the crude has softened, so the chemical prices will eventually get softened.

    — Sanjay Tibrewala

Overall Growth

  • Annual growth targets Overall Growth · FY26 · Medium confidence ambitious annual growth targets
    With a clear road map, a strong order pipeline and ongoing diversification into high potential sectors, we are confident in delivering value to stakeholders and achieving our ambitious annual growth targets.

    — Sanjay Tibrewala

What to watch in Q1 FY26

Greenfield expansion commissioning

Q2 FY26
Current Under construction, hoping to initiate by September 2025
Target Commencement of operation by Q2 FY26

Why it matters

This is a major capacity addition and a key growth driver for the company's future revenue streams.

We are happy to report that it is progressing well and we aim to commence operation by Q2 Financial Year 2026.

Risks & concerns

  • Geopolitical tensions and trade disruptions

    medium

    Led to certain deliveries being postponed in Q4 FY25, though expected to be fulfilled in the current financial year.

    Management acknowledged

  • Temporary softness in FMCG, cleaning, and hygiene segment volumes

    medium

    Attributed to price rise in detergent raw materials and consumer shift to cheaper products, but underlying demand fundamentals remain intact.

    Management acknowledged

  • Political situation impacting AquaStrike Premium domestic order flow

    low

    Temporary delay in state government focus due to recent political situation, but expects faster approaches now that things have settled.

    Management acknowledged

Q&A highlights

5 direct
Reasons for lower EBITDA margins in Q4 Direct
there has been a lot of sales promotional expenses being done by the Company, and which has already been going very positive, lot of acquisitions, a lot of new product developments, a lot of promotional activities which are all going, and that has also led to lower EBITDA margins for the quarter.

Explains the margin compression despite stable gross margins, indicating strategic investments for future growth.

Asked by Suraj Khaitan

Softening of FMCG vertical performance Direct
quite a price rise in the detergent raw material prices in FMCG sectors, it was already fair from November, December, the chemical prices have gone up. And then what happens generally when these things do happen, it's like there has always been flexible in the demand and such situations where the performance boosters and the products and the sustainable solutions which we offer for such FMCG players, their consumption decreases because in turn they also have softening in their demand.

Provides detailed reasons for the volume softness in a key segment and indicates a transitional phase with expected recovery.

Asked by Kautuk Yemdey

Investments and Capex for new plant Direct
we have already had a fundraise, and thereafter we have invested in the new plant which is being setup. So we have almost gone for a fundraise of Rs. 342 crores, out of which the promoter has contributed Rs. 44 crores actually. And some of it has to be paid upon the 18 months of the warrants as such when the time comes in. So this is kind of investment and there is a lot of capital in work progress also going on now. So maybe by September you will find more clarity on what all things have been installed, because we are hoping that before September we will be initiating our plant in Ambarnath.

Clarifies the source of funds and timeline for the new plant commissioning, which is a significant growth driver.

Asked by Kautuk Yemdey

AquaStrike Premium approvals and domestic order flow Partial
we have taken the Central Insecticide Board approval which is from the ministry. At the same time, we have invested and we have got the approval from Hopkins Institute... we have already submitted to several state governments. There is quite of interest coming up. But due to the political situation which happened in the last two weeks back, the focus by most of the states and the central was not on this at the moment. However, it looks like now things have settled down. And things are getting back to track and there will be a faster approaches on this line.

Details the regulatory progress and initial market interest for a new product, while also highlighting a temporary political hurdle for domestic orders.

Asked by Ajay Kumar

Revenue breakup between textile and FMCG, and volume growth/degrowth Direct
Almost like 70% of the revenues is textile specialties for the entire year, 73% at the moment for this year... The textile has in fact gone up by 15% in terms of volume. And the revenue of the same has gone up by almost 10%. The gap has been coming up in the health and hygiene, the cleaning sector, and that has brought down the overall performance in terms of volume in the numbers.

Provides crucial segment-wise performance details, clarifying that textile is growing while health & hygiene is the primary reason for overall volume degrowth.

Asked by Bhavin Soni

Oil & Gas segment capacity and future capex requirements Direct
our capacities are fungible... in the same machinery setup we can make these kind of products. So we do not need a separate investment for oil and gas. However, having said that, there can be some requirements specific for product lines because some products are like in powder forms or this and that where we will need Rs. 20 crores, Rs. 30 crores of investment... we have enough of internal accruals and also generating good cash, so I do not think we have to worry on the cost of the expansion on that line for production capacities in future.

Explains the fungible nature of capacity for new segments and the limited additional capex required, indicating efficient capital deployment for growth.

Asked by Rushabh

Confidence in warrant conversion by promoter Partial
the point is that it is of November, there is six months to go, number one. Number two, the Company has enough of cash which can be utilized for any inorganic opportunities or organic opportunities. Organically, like I said, we have already invested Rs. 115 crores by now and right now we have Rs. 355 crores of liquid cash and cash equivalents available for the expansion. So, even if that does not happen, it does not affect the working of the Company or any opportunity of the Company to be missed out, number one. And number two, as you must be knowing, if that 75% does not come in, the 25% is retained by the Company tax free and directly added to the reserves.

Addresses investor concern about potential dilution from warrants and management's contingency plan, highlighting financial flexibility and minimal impact on operations.

Asked by Anirudh Daga

3 min read 6 chapters

Detailed narrative

Overview of FY25 Financial Performance

Fineotex Chemical Limited reported a flattish total income of Rs. 558 crores for FY25. Gross profit stood at Rs. 205 crores, maintaining stable margins at 38.57%. However, EBITDA softened by 222 basis points to 23.85% (Rs. 127 crores) due to strategic investments in CAPEX and brand-building initiatives. PAT for the year was Rs. 109 crores, a decrease from Rs. 121 crores in the previous year, resulting in a PAT margin of 20.48%. The company generated Rs. 69.33 crores in operating cash flows, with a healthy CFO to EBITDA ratio of 54.50%.

Strategic Diversification & New Product Launches

The company is actively diversifying its business portfolio, with water treatment and oil & gas segments delivering strong performance and substantial increases in both volumes and value contributions. A key innovation is AquaStrike Premium, a biotechnology-based mosquito control solution formulated with Azadirachtin, which has received Central Insecticide Board approval and demonstrated a 100% mortality rate in 2-3 hours. This product is poised to open new opportunities in the public health domain. Fineotex also added 25 new customers and developed 30 new products during Q4 FY25, reinforcing its focus on innovation.

Greenfield Expansion and Capacity Outlook

Fineotex's greenfield expansion initiative is progressing well and is targeted to commence operations by Q2 FY26. This new facility will add 15,000 metric tonnes per annum of capacity, increasing the total installed capacity to 1,20,000 metric tonnes. The company has invested approximately Rs. 110-115 crores in CAPEX over the last 15 months, including the new plant and corporate office. With a current cash balance of Rs. 352 crores and strong internal accruals, management is confident in funding future expansions without external debt concerns. Capacity utilization for FY25 was approximately 59-60%.

FMCG Segment Challenges and Recovery Outlook

The FMCG, cleaning, and hygiene segment experienced a temporary softness in volumes during Q4 FY25, with the detergent/FMCG sub-segment seeing an 18% volume drop. This was attributed to rising raw material prices and a consumer shift towards cheaper products and liquid detergents. Management views this as a transitional quarter, with underlying demand fundamentals remaining intact. They anticipate a pickup in volumes in the coming quarters, driven by geographical expansion, new product launches, and increasing demand for sustainable solutions.

Market Opportunities and Global Footprint

The textile chemical segment remained stable, with volumes growing 15% and revenue 10% in FY25, and a strong revival is expected from June onwards. Fineotex is actively pursuing opportunities in the Middle East and US markets for oil & gas, noting that global companies are diverting supply chains to India. The company's capacities are fungible, allowing it to produce various chemicals for these industries with minimal additional capex (estimated Rs. 20-30 crores for specific product lines). The India-UK Free Trade Agreement is also expected to benefit Fineotex by improving market access and reducing tariffs.

Capital Allocation and Financial Strength

The company undertook a fundraise of Rs. 342 crores in FY25, with the promoter contributing Rs. 44 crores. Further warrant conversions by the promoter (Rs. 33 crores remaining) are expected by November. Management emphasized that the company's strong cash position of Rs. 352 crores and robust internal accruals provide ample liquidity for both organic and inorganic growth opportunities. They stated that even if the remaining warrant conversions do not fully materialize, it would not affect the company's operations or growth plans, as the retained 25% would be tax-free and added to reserves.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Chemicals earnings calls